Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Is Ablative Radio-iodine Necessary for Low Risk Differentiated Thyroid Cancer Patients

NCT01398085 is registered in ClinicalTrials.gov with University College, London as lead sponsor.

NCT NCT01398085
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01398085 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Is Ablative Radio-iodine Necessary for Low Risk Differentiated Thyroid Cancer Patients
Lead sponsor
University College, London
Phase
Phase 2/3
Overall status
Active, not recruiting
Start date
June 26, 2012
Completion date
March 31, 2031
Enrollment
504 (actual)
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

thyroid cancer, thyroid neoplasms